In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow properties.
BACKGROUND
Hyaluronic acid (HA) is present in many tissues; its presence in serum may be related to certain inflammatory conditions, tissue damage, sepsis, liver malfunction and some malignancies. In the present work, our goal was to investigate the significance of hyaluronic acid effect on erythrocyte flow properties. Therefore we performed in vitro experiments incubating red blood cells (RBCs) with several HA concentrations. Afterwards, in order to corroborate the pathophysiological significance of the results obtained, we replicated the in vitro experiment with ex vivo RBCs from diagnosed rheumatoid arthritis (RA) patients, a serum HA-increasing pathology.


METHODS
Erythrocyte deformability (by filtration through nucleopore membranes) and erythrocyte aggregability (EA) were tested on blood from healthy donors additioned with purified HA. EA was measured by transmitted light and analyzed with a mathematical model yielding two parameters, the aggregation rate and the size of the aggregates. Conformational changes of cytoskeleton proteins were estimated by electron paramagnetic resonance spectroscopy (EPR).


RESULTS
In vitro, erythrocytes treated with HA showed increased rigidity index (RI) and reduced aggregability, situation strongly related to the rigidization of the membrane cytoskeleton triggered by HA, as shown by EPR results. Also, a significant correlation (r: 0.77, p < 0.00001) was found between RI and serum HA in RA patients.


CONCLUSIONS
Our results lead us to postulate the hypothesis that HA interacts with the erythrocyte surface leading to modifications in erythrocyte rheological and flow properties, both ex vivo and in vitro.
Luquita
A
A
Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Cátedra de Física Biológica, Santa Fe 3100, 2000 Rosario, Argentina. luquitale@hotmail.com
Urli
L
L
Svetaz
M J
MJ
Gennaro
A M
AM
Giorgetti
M E
ME
Pistone
G
G
Volpintesta
R
R
Palatnik
S
S
Rasia
M
M
D001172:Arthritis, Rheumatoid / Q000097:blood; D001809:Blood Viscosity; D003598:Cytoskeletal Proteins / Q000378:metabolism; D004578:Electron Spin Resonance Spectroscopy; D004907:Erythrocyte Deformability; D004910:Erythrocyte Membrane / Q000378:metabolism; D004912:Erythrocytes / Q000166:cytology / Q000378:metabolism*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology*; D008875:Middle Aged; D055675:Viscosupplements / Q000494:pharmacology*
D003598:Cytoskeletal Proteins; D055675:Viscosupplements; D006820:Hyaluronic Acid